Organ‐specific Modification of Tumor Development by Low‐dose Combinations of Agents in a Rat Wide‐spectrum Carcinogenesis Model
Open Access
- 1 July 1991
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (7) , 784-792
- https://doi.org/10.1111/j.1349-7006.1991.tb02703.x
Abstract
The combined effects of low doses of various carcinogens and carcinogenesis modifiers on tumor development were investigated by using a wide‐spectrum organ carcinogenesis model in F344 rats. These agents were administered as three groups: (1) a group of known hepatocarcinogens; (2) a group of nitroso compounds having various target organ specificities; and (3) a group of antioxidants having various inhibiting or enhancing activities depending on the target organ. Doses were used which were generally below the known effective level for the individual chemical. These groups of chemicals were administered with or without prior administration of N‐diethylnitrosamine (100 mg/kg body wt., i.p.), N‐methylnitrosourea (4 × 20 mgAg body wt., i.p.) and dihydroxy‐di‐N‐propylnitrosamine (0.1% in drinking water for 2 weeks). The hepatocarcinogen group in combination with various nitroso compounds increased the incidences of liver hyperplastic nodules and hepatocellular carcinomas. In contrast, incidences were clearly reduced when the hepatocarcinogens and/or the nitroso compounds were administered in combination with the antioxidants. For the urinary bladder, the combination with nitroso compounds and antioxidants enhanced cancer development, and the addition of hepatocarcinogens further increased tumorigenesis. For the glandular stomach, additive effects on the numbers of pepsinogen isozyme 1‐altered pyloric glands, a putative preneoplastic lesion, were produced by the combination treatment of antioxidants and the nitroso compounds. No synergistic effects on tumor development were seen in other organs. The results of the present study demonstrated that combinations of various compounds at low doses can additively or synergistically exert either enhancing or inhibitory effects on the development of preneoplastic and neoplastic lesions in different organs in a single model having a wide spectrum of organ effects.Keywords
This publication has 54 references indexed in Scilit:
- Combination Effects of Forty Carcinogens Administered at Low Doses to Male RatsJapanese Journal of Cancer Research, 1989
- Changes in urine composition, bladder epithelial morphology, and DNA synthesis in male F344 rats in response to ingestion of bladder tumor promotersToxicology and Applied Pharmacology, 1989
- Modification by sodium l-ascorbate, butylated hydroxytoluene, phenobarbital and pepleomycin of lesion development in a wide-spectrum initiation rat modelCancer Letters, 1989
- WIDE‐SPECTRUM INITIATION MODELS: POSSIBLE APPLICATIONS TO MEDIUM‐TERM MULTIPLE ORGAN BIOASSAYS FOR CARCINOGENESIS MODIFIERSJapanese Journal of Cancer Research, 1988
- Modification by α-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamineCancer Letters, 1987
- Placental Glutathione S-Transferase (GST-P) as a New Marker for Hepatocarcinogenesis: In Vivo Short-Term Screening for HepatocarcinogensToxicologic Pathology, 1987
- Enhancement of BHA-induced proliferative rat forestomach lesion development by simultaneous treatment with other antioxidantsCarcinogenesis: Integrative Cancer Research, 1987
- Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamineCarcinogenesis: Integrative Cancer Research, 1984
- Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytolueneCancer Letters, 1983
- Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of γ-glutamyl transpeptidase-positive foci development in the liver of ratsCarcinogenesis: Integrative Cancer Research, 1983